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Flavone acetic acid (FAA, NSC 347512) is a synthetic flavonoid
that possesses striking anti-tumour activity in a wide variety of
solid tumours in murine models of cancer (Finlay et al, 1988;
Cummings and Smyth, 1989; Hill et al, 1991; Bowler and Pearson,
1992). Experimental evidence suggests that FAA kills tumour cells
indirectly by reducing tumour blood flow causing ischaemic
conditions within the tumour (Bibby et al, 1989; Zwi et al, 1989;
Madhevan and Hart, 1991) without effecting systemic blood flow
(Bibby and Double, 1993). In addition to vascular collapse, the
release of cytokines such as tumour necrosis factor (TNF)-a,
interferon-a and interferon-g by immune system cells plays an
important role in the tumouricidal properties of FAA (Ching and
Bagueley, 1987; Pratesi et al, 1990; Futami et al, 1991; Chabot
et al, 1993). Furthermore, ample data exist suggesting that nitric
oxide (NO) production within the tumour may also contribute to
the cytotoxic activity of FAA either by direct toxicity to tumour
cells or by altering tumour blood flow (Thomsen et al, 1990, 1991,
1992; Harris and Thorgeirsson, 1997). Unfortunately, FAA failed
to illicit a similar response in human clinical trials, leading to a
decreased interest in examining the molecular pathways involved
in its anti-tumour properties in the mouse. A greater understanding
of the molecular pathways involved in the anti-tumour actions of
FAA might suggest rational structural modifications to FAA,
combination strategies, and/or identify novel molecular targets for
anti-tumour therapies.
In this study, we have chosen to examine the anti-proliferative
effects of FAA. While the effects of other flavonoids on the cell
cycle progression have been examined to extent, surprisingly no
similar study has been performed with FAA. The flavonol
quercetin arrests human gastric cancer cells at the G1/S boundary
(Yoshida et al, 1990) whereas the isoflavone genistein blocks
proliferation of the same cell line in G2/M (Matsukawa et al,
1993). The flavone apigenin has been shown to arrest mouse
keratinocytes in G2/M (Sato et al, 1994; Lepley et al, 1996), while
the flavone flavopirodol is capable of blocking cell proliferation in
both G1 and G2 in A549 lung carcinoma cells (Bible and
Kaufman, 1996; Carlson et al, 1996). Hence, there is no clear link
between flavonoid structure and their ability to arrest cell growth
in a particular phase of the cell cycle. We have found that FAA
causes rat mammary carcinoma cells (and other cell types) to
arrest in G2/M and that this effect is accompanied by increased
cdc2 kinase activity.
MATERIALS AND METHODS
Cell culture
NMU cells (ATCC, Rockville, MD, USA) were obtained at
passage number 21. Cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 4 mM glutamine and
4.5 g glucose l–1, and supplemented with 10% fetal bovine serum,
100 units penicillin ml–1, 100 mg streptomycin ml–1 and 25 mM
HEPES buffer (Biofluids, Rockville, MD, USA). All experiments
were conducted using cells between passages 25 and 48.
For all experiments, confluent flasks of NMU cells were
trypsinized and split 1:10, 2–3 days prior to FAA treatment.
Floating and adherent cells for flow cytometry were pelleted by
centrifugation at 600 g for 5 min. For experiments involving the
MTS/PMS assay, 2000 cells were seeded per well in replicates of
six per experimental treatment in 96-well plates.
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Flavone 8-acetic acid (FAA) was obtained from the NIH Drug
Synthesis Branch. Ammoniumpyrrolidinedithiocarbamate (ADPC)
was obtained from Alexis Corporation (San Diego, CA, USA). 
S-ethylisothiourea-HBr (SEIU) and L-cycloserine were obtained
from Biomol Research Laboratories (Plymouth Meeting, PA,
USA). Radiolabelled [g-32P]ATP was obtained from Amersham
Life Science, Inc. (Arlington, IL, USA). All other chemicals 
were obtained from Sigma Chemical Co. (St Louis, MO, 
USA).
Flow cytometry
Cell pellets were resuspended in 0.5 ml of HBSS and then fixed by
adding 4.5 ml of ice-cold 70% ethanol. Cells were stained with
propidium iodide for cell cycle analysis using the Becton
Dickinson Cycle Test Plus DNA Reagent Kit (Becton Dickinson,
San Jose, CA, USA) and filtered through a 48 mM nylon mesh
(Tetko, Briarcliff Manor, NY, USA). Samples of 25 000 events
were collected on a Becton Dickinson FACSort (Becton
Dickinson) using the Cell Quest software package (Version # 1.0)
and gated to remove doublets and debris.
Cell proliferation assay
Cell proliferation was quantitated using the MTS (3-(4,5-di-
me-thylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sul-
phonyl-2-H-tetrazolium, inner salt)–PMS (phenazine methosul-
phate) method (Promega, Madison, WI, USA). Briefly, 20 ml of an
MTS–PMS mixture (20:1) was added to 96-well plates containing
100 ml of culture media per well. Plates were incubated at 37°C for
1 h and absorbance read at 490 nm. Each well was run in replicates
of six wells, with the high and low absorbances rejected and
averages of the remaining four wells used to calculate cell prolifer-
ation.
Immunoblot analysis
Cell pellets were resuspended in 50 ml of loading buffer (Novex,
San Diego, CA, USA), sonicated (2 ´ 10-second pulses), vortexed
briefly, snap-frozen in liquid nitrogen and stored at –80°C until
assayed. Protein concentrations were quantitated using the BCA
method (Pierce, Rockford, IL, USA) and 20-mg aliquots of total
protein were loaded in each lane, electrophoresed and transferred
to a nitrocellulose membrane. The membrane was placed in 5%
milk (BioRad) in TBS (Tris-buffered saline) for 8 h, rinsed three
times in TTBS (0.05% Tween-20 in TBS), followed by 16-h incu-
bation in SuperBlock (Pierce). Incubation with 1:1000 dilution of
rabbit anti-rat cyclin B1 (Santa Cruz, Santa Cruz, CA, USA)
was carried out for 8 h, washed three times with TTBS, incubated
in biotinylated goat anti-rabbit antibody (1:2000 in TTBS) for
1 h, washed three times with TTBS, incubated with strepavidin–
biotinylated alkaline phosphatase complex (1:3000 in TTBS) for
1 h, and washed again three times with TTBS. Bands were
detected using Bio-Rad AP Color Development kit.
Mitotic index and cytogenetic analysis
Exponentially growing NMU cells were treated with FAA 
(250 mg ml–1) or colcemid (0.5 mg ml–1). This concentration of
FAA was chosen because it was shown by flow cytometry to be
the most effective in causing a sustained G2/M block. Mitotic
indices and chromosome ploidy were determined after 8, 16, 24,
36 and 48 h of FAA or colcemid treatment. For the mitotic indices
the cells were cultured on glass coverslips. At the indicated time
points, the medium was removed, the cells were washed in PBS,
fixed in absolute methanol, stained with DAPI or Giemsa, and
mounted. Two coverslips (1000 cells per coverslip) were exam-
ined for each time point. Chromosome ploidy was determined in
exponentially growing cells, cultured in 100-mm petri dishes. The
chromosomes were prepared by a standard technique, using hypo-
tonic potassium chloride treatment, acetic acid–methanol fixation,
and air-drying of the slides. For each time point, 200 Giemsa-
stained metaphases with minimal chromosome overlapping were
recorded and the chromosomes were counted on the screen.
RNA blotting
Total cellular RNA was obtained from the cell pellets using
Qiagen Rneasy Kit (Qiagen, Chatsworth, CA, USA), quantitated
using the GENE Quant II (Pharmacia, Piscataway, NJ, USA) and
concentrated by use of a SpeedVac. Twenty micrograms of total
RNA were denatured in formaldehyde and formamide and elec-
trophoresed through a 1% agarose gel containing formaldehyde
alongside the appropriate RNA molecular weight ladder (Gibco-
BRL, Gaithersburg, MD, USA). Ethidium bromide-stained gels
were photographed to confirm RNA quality and equal loading of
lanes. Gels were washed four times in DEPC water and transferred
to a nylon-supported nitrocellulose membrane. The membrane
was pre-hybridized with ExpressHyb (Clontech, Palo Alto, CA,
USA) for 60 min at 68°C, followed by hybridization with a cyclin
B1 probe made by random primer labelling of a 400 bp rat cyclin
B1 cDNA (kind gift of Dr Michael Jensen, NCI) for 60 min at
68°C, washed in 2 ´ sodium–saline citrate (SSC)/0.05% sodium
dodecyl sulphate (SDS) (3 ´ 10 min, room temperature), 0.1 ´
SSC/0.1% SDS (10 min, 50°C), and 0.1 ´ SSC/0.1 % SDS (30
min, 50°C). Membranes were exposed to a phosphoimaging
screen for 48–72 h and images captured and band intensities quan-
tified using a Storm phosphoimager. Dehybridization of probes
from the membranes was achieved by washing in 0.5% SDS
(10 min, 90°C). Membranes were then re-hybridized and intensi-
ties were quantitated using a glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) cDNA probe (kind gift of Dr E Fernandez-Salas
and Dr S Yuspa, NCI) as described above.
Cdc2 kinase activity assay
Cell pellets were obtained as described above. P34cdc2 kinase
activity was determined using the SignaTECT cdc2 Protein Kinase
Assay System (Promega). Each sample was assayed in triplicate
(5 ml per replicate) as described by Promega. Protein concentra-
tions were determined using the Pierce BCA method.
RESULTS
FAA induces a G2/M cell cycle arrest
Figure 1 shows the effect of FAA on the cell cycle of the NMU rat
mammary carcinoma cells as a function of concentration and time.
A sustained G2/M cell cycle arrest was observed at 250 mg ml–1 of
FAA over a 24-h time period while no effect was observed at 
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G2/M cell cycle arrest which was apparent at 8 h but had reversed
towards the control level at 24 h. To determine if the cell cycle
arrest was reversible after the NMU cells were exposed to 
250 mg ml–1 FAA for 24 h, cell proliferation was measured after
the removal of the FAA, using the MTS–PMS method. Figure 2
shows that cell proliferation recovered to levels of the untreated
control 72 h after the removal of FAA.
Cyclin B1 levels in NMU cells exposed to FAA
Northern blot analysis showed 1.6 and 2.4 kb transcripts for cyclin
B1. Densitometric readings showed no changes in the cyclin B1
RNA levels (Figure 3A) and immunoblot analysis showed no
differences following 24-h exposure to FAA (250 mg ml–1)
(Figure 3B).
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Figure 1 FAA-mediated cell cycle effects on rat mammary carcinoma cells, analysed by flow cytometry
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Figure 2 Recovery of rat mammary carcinoma cell proliferation after removal
of FAA. At 72 h after removal of FAA, cellular proliferation was statistically
identical to that of the untreated control (P < 0.05, n = 3). Error bars
represent standard error of the means1908 NJ Panaro et al
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Figure 3 Effects of FAA on cyclin B1 levels. (A) Northern blot analysis of
cyclin B1 RNA expression. Cyclin B1 expression is represented by 1.6- and
2.4-kDa transcripts. To evaluate the quantity and quality of the RNA, the blots
were rehybridized with a GADPH probe and stained with ethidium bromide.
(B) Immunoblot analysis for cyclin B1. The percentage of cells in the G2/M
phase are shown below the blots
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Figure 4 Cdc2 kinase activity in FAA-treated NMU cells. Cdc2 kinase activity
was significantly increased after a 12-h exposure to 250 mg ml–1 FAA
(P < 0.05, n = 3). Error bars represent standard error of the means
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C
D
Figure 5 Representative metaphases from the FAA-treated NMU rat mammary carcinoma cells: (A) triploid metaphases; (B) hexaploid metaphases; 
(C) C-mitosis with centromeres still attached; (D) C-mitosis with centromeres completely separated. Arrows indicate large acrocentric chromosomes which 
were characteristic for the NMU rat mammary carcinoma cellsCdc2 kinase activity is increased by FAA
Figure 4 shows cdc2 kinase activity in control and FAA-treated
NMU cells 6 and 12 h after 250 mg ml–1 FAA treatment.
Insignificant increase in the kinase activity was observed at 6 h,
whereas a statistically significant threefold increase was observed
after a 12-h exposure to 250 mg ml–1 FAA.
Cytogenetic analysis
The NMU rat mammary carcinoma cell line displayed an aneu-
ploid chromosome constitution with an abnormal chromosome
number and structural abnormalities (Figures 5A,B and 6). A
predominant population (92% of the cells) had a triploid number,
ranging from 65 to 74 chromosomes (3n). A minor cell population
had near hexaploid number, ranging from 130 to 146 (6n). The
triploid cells had a distinctive large abnormal acrocentric chromo-
some which was duplicated in the hexaploid cells (Figure 5A,B).
Morphological analysis was carried out on the FAA-G2/M blocked
cells and compared with cells treated with colcemid, an effective
mitotic arrestant. There were minor differences in the mitotic
indices between the FAA and colcemid treated cells with a peak
mitotic accumulation for both compounds at the 24-h time point
(Figure 6A).
To determine the nature of the mitotic block, chromosomes were
examined after 8, 16, 24, 36 and 48 h of FAA or colcemid treat-
ment. The two compounds showed a similar distribution of triploid
and hexaploid cells up to 16 h (Figure 6B). Thereafter, the inci-
dence of hexaploidy increased significantly in the colcemid treated
cells and became the predominant population at 48 h. In the FAA
treated cells, however, only a small increase in the incidence of
hexaploid cells occurred after the 16th time point (Figure 6B). This
suggests that only a small fraction of the cells at higher DNA
ploidy, which are reflected in the G2/M peak of the histograms
(Figure 1), are G1 cells. When FAA was removed after 6 h
exposure, there was no increase in hexaploid cells for a period
up to 48 h (data not shown).
Metaphases with diplochromosomes, reflecting endoreduplica-
tion, were observed in 2–3% of the colcemid-treated cells, but in
none of the FAA-treated cells (Figure 6). A striking feature of the
cells arrested in metaphase after FAA treatment was the appear-
ance of C-mitosis, known to be caused by colcemid and named
accordingly (Therman, 1980). C-metaphases exhibited separated
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Figure 6 Mitotic indices and ploidy in the NMU rat mammary carcinoma
cells, treated with FAA or colcemid for 8, 16, 24, 36 and 48 h. (A) Mitotic
indices at indicated time points of FAA (dotted line) and colcemid (solid line)
treatment. (B) Chromosome ploidy was determined in FAA (F) and colcemid
(C) treated cells at indicated time points as per cent (%) triploid (3n) and
hexaploid (6n) metaphases. The columns representing metaphases from the
FAA-treated cells are: triploid (solid black); hexaploid (heavy stripes). The
columns representing metaphases from the colcemid treated cells are (heavy
stripes); hexaploid (light stripes)
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Figure 7 Inhibitory effects of the sphingosine kinase inhibitor, L-cycloserine,
on the FAA-mediated cell cycle effect, analysed by flow cytometrychromatids with the centromere still attached in most mitotic
figures and complete separation in some metaphases (Figure 5C,
D). The incidence of C-metaphases increased from 20% at 8 h to
40% and 70% at 16 h and 24 h of FAA treatment. A similar
frequency of C-mitosis was observed in the colcemid treated
cultures. C-mitosis was not observed in cultures exposed to either
chemical for 3–4 h prior to cell harvest.
L-cycloserine, an inhibitor of sphingosine biosynthesis,
blocks the ability of FAA to arrest cell proliferation
Co-administration of L-cycloserine with FAA blocked the cell
cycle arrest in a dose-dependent manner (Figure 7). At 25 mg ml–1,
L-cycloserine had little effect on the FAA-induced cell cycle arrest.
However, at 100 mg ml–1 L-cycloserine blocked the FAA-induced
G2/M cell cycle arrest.
DISCUSSION
Previous research conducted in our laboratory has demonstrated
the ability of FAA to inhibit the proliferation of human umbilical
vein endothelial cells (HUVEC) and human lung microvascular
endothelial cells (HMVEC-L) in vitro (Lindsay et al, 1996). While
the present study has mainly focused on mammary carcinoma
cells, we observed a G2/M cell cycle arrest in other cell types
tested, including HUVEC and HMVEC-L, as well as rat liver
epithelial cells (RLE) and v-raf/v-myc transformed RLE (unpub-
lished observations). The G2/M arrest in mammary carcinoma
cells in vitro occurred at doses previously shown to have anti-
tumour effects in rodents.
Major cell cycle transitions are regulated by a family of
serine/threonine kinases known as cyclin-dependent kinases. cdc2
regulates the G2/M transition by phosphorylating a key group of
proteins (Mitra et al, 1996; Wu et al, 1996). Protein levels of cdc2
remain constant throughout the cell cycle and its kinase activity is
therefore not regulated at the level of transcription but rather by its
association with cyclin B and by its phosphorylation state (Draetta
and Beach, 1988). Formation of cdc2–cyclin B complex is neces-
sary for the G2/M transition to take place and the cells to enter
mitosis. The FAA-mediated cell cycle arrest was not associated
with decreased cyclin B1 levels. Thus it would appear that the
observed G2/M cell cycle arrest was not the result of decreased
cyclin B1 levels. Suppressed cyclin B levels have been observed in
the G2/M arrest of mouse keratinocytes treated with the flavonoid
apigenin (Lepley et al, 1996) and the G2/M arrest in HeLa cells
following ionizing radiation (Muschel et al, 1991, 1993).
Interestingly, there was an increase in cdc2 kinase activity after
a 12-h exposure to FAA. Elevated levels of cdc2 kinase activity
have been observed in HeLa cells treated with colcemid,
nocodozole or taxol, each of which causes cells to arrest in G2/M,
and that this cdc2 hyperactivation may be necessary for taxol-
induced apoptosis (Kung et al, 1990; Donaldson et al, 1994).
Cytogenetic analysis of the NMU rat mammary carcinoma cells
showed that FAA had colcemid-like effect with accumulation of
C-metaphases. A recent report on mutations of mitotic checkpoint
genes in human colorectal cancer cell lines has provided a new
insight into the understanding of chromosomal instability which
leads to aneuploidy in cancer (Cahill et al, 1998). Colorectal
cancer cell lines with chromosomal instability were found to be
unresponsive to a mitotic block by colcemid due to a mutational
inactivation of the human homologue of the yeast BUB1 gene
(Cahill et al, 1998). In our study, the aneuploid NMU rat
mammary carcinoma cells showed a normal response to colcemid
and were also arrested by FAA. Further characterization of the cell
cycle effect of FAA in near diploid versus aneuploid cancer cell
lines may reveal important new findings on the cell cycle effect of
FAA, which could resurrect an interest in this previously failed
chemotherapeutic agent.
It has been proposed that FAA may act as a free radical and
possess pro-oxidant properties (Candeias et al, 1993; Cao et al,
1997; Hodnick et al, 1997). This is supported by our findings
showing that the antioxidants ADPC and the superoxide scavenger
Tiron block the FAA-mediated cell cycle arrest (data not shown).
We also considered the possibility that FAA as a free radical and a
stimulator of pro-inflammatory cytokines could act through stimu-
lation of acidic pH-dependent sphingomyelinase (ASMase)
(Feinstein et al, 1995; Adam et al, 1996). L-cycloserine, an
ASMase inhibitor, was found to block the FAA-mediated cell
cycle effect. Studies by Pahan et al (1998) have shown that simul-
taneous treatment of astrocytes with ASMase and cytokines
resulted in increased levels of NO. Hence, we asked the question if
ASMase was involved in the cell cycle arrest through stimulation
of the NO pathways. It was particularly relevant since our previous
study on FAA-mediated anti-tumour effect on the mouse tumours
implicated involvement of NO (Harris et al, 1997). However, NOS
inhibitors had no effect on the FAA-mediated cell cycle arrest in
the present study (not shown), suggesting the NO was not
involved.
We have demonstrated that FAA induces a sustained G2/M
arrest comparable to that caused by colcemid in rat mammary
carcinoma cells. The data indicate that cdc2 is targeted by the
growth arresting effect of FAA and that generation of reactive
oxygen species may play a role.
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